Can Bydureon Bounce Back? Amylin's Proposed Cardio Safety Trial Is A Faster Option
This article was originally published in The Pink Sheet Daily
Executive Summary
If FDA approves the new protocol, a QT prolongation study required to refile Bydureon could commence this quarter.